Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

480 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PARP inhibition in BRCA2-mutated prostate cancer.
Nientiedt C, Tolstov Y, Volckmar AL, Endris V, Bonekamp D, Haberkorn U, Jäger D, Sültmann H, Stenzinger A, Hohenfellner M, Grüllich C, Duensing S. Nientiedt C, et al. Among authors: stenzinger a. Ann Oncol. 2017 Jan 1;28(1):189-191. doi: 10.1093/annonc/mdw445. Ann Oncol. 2017. PMID: 27687312 Free article. No abstract available.
[Molecular diagnostics in pathology].
Stenzinger A, Penzel R, Endris V, Weichert W. Stenzinger A, et al. Dtsch Med Wochenschr. 2013 May;138(20):1061-8. doi: 10.1055/s-0033-1343106. Epub 2013 May 13. Dtsch Med Wochenschr. 2013. PMID: 23670263 Review. German.
Molecular diagnostic profiling of lung cancer specimens with a semiconductor-based massive parallel sequencing approach: feasibility, costs, and performance compared with conventional sequencing.
Endris V, Penzel R, Warth A, Muckenhuber A, Schirmacher P, Stenzinger A, Weichert W. Endris V, et al. Among authors: stenzinger a. J Mol Diagn. 2013 Nov;15(6):765-75. doi: 10.1016/j.jmoldx.2013.06.002. Epub 2013 Aug 21. J Mol Diagn. 2013. PMID: 23973117 Free article.
Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm.
Stenzinger A, Endris V, Pfarr N, Andrulis M, Jöhrens K, Klauschen F, Siebolts U, Wolf T, Koch PS, Schulz M, Hartschuh W, Goerdt S, Lennerz JK, Wickenhauser C, Klapper W, Anagnostopoulos I, Weichert W. Stenzinger A, et al. Oncotarget. 2014 Aug 15;5(15):6404-13. doi: 10.18632/oncotarget.2223. Oncotarget. 2014. PMID: 25115387 Free PMC article.
KIT mutations in primary mediastinal B-cell lymphoma.
Nagel PD, Stenzinger A, Feld FM, Herrmann MD, Brüderlein S, Barth TF, Marienfeld R, Endris V, Weichert W, Debatin KM, Westhoff MA, Lessel D, Möller P, Lennerz JK. Nagel PD, et al. Among authors: stenzinger a. Blood Cancer J. 2014 Aug 22;4(8):e241. doi: 10.1038/bcj.2014.61. Blood Cancer J. 2014. PMID: 25148223 Free PMC article. No abstract available.
Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differences.
Kriegsmann M, Endris V, Wolf T, Pfarr N, Stenzinger A, Loibl S, Denkert C, Schneeweiss A, Budczies J, Sinn P, Weichert W. Kriegsmann M, et al. Among authors: stenzinger a. Oncotarget. 2014 Oct 30;5(20):9952-65. doi: 10.18632/oncotarget.2481. Oncotarget. 2014. PMID: 25296970 Free PMC article.
Ataxia-telangiectasia-mutated protein kinase levels stratify patients with pancreatic adenocarcinoma into prognostic subgroups with loss being a strong indicator of poor survival.
Kamphues C, Bova R, Bahra M, Klauschen F, Muckenhuber A, Sinn BV, Warth A, Goeppert B, Endris V, Neuhaus P, Weichert W, Stenzinger A. Kamphues C, et al. Among authors: stenzinger a. Pancreas. 2015 Mar;44(2):296-301. doi: 10.1097/MPA.0000000000000248. Pancreas. 2015. PMID: 25423555
480 results